The Information· 1h agoOpenAI Buys Drug Development Company Orchestra Bio
OpenAI acquires Orchestra Bio, an AI drug-development agent startup
Partnership
OpenAI is buying Orchestra Bio, a startup that builds AI agents to help biotech and pharmaceutical companies with drug development, the AI lab announced on Tuesday.
The acquisition is an early move toward a goal long-touted by OpenAI executives of using the company's technology to help with drug development.